Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04309305 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Robotic Exoskeleton Assisted Gait Post Stroke

Study acronym: RE-Assist
StatusEnrolling by Invitation
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 6, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: May 1, 2024 to May 1, 2026
    • Study completion date: Sep 1, 2024 to Sep 1, 2026
    v5
  2. Phase: Not applicable to Phase 1v4
  3. Study completion date: Aug 1, 2024 to Sep 1, 2024v3
  4. Primary completion date: Jan 2025 to May 1, 2024
    • Study completion date: Aug 2025 to Aug 1, 2024
    • Start date: Feb 4, 2020 to Jan 30, 2020
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The current investigation takes advantage of both a progressive and adaptive assist-as-needed massed practice and time-sensitive neuroplasticity through exoskeleton assisted walking in order to induce greater recovery-oriented CNS plasticity and consequent gains in more independent walking.
Trial Details
NCT Number NCT04309305
Lead Sponsor Kessler Foundation
Conditions
(from sponsor)		 CVA, Gait, Hemiplegic
Related terms Gait Disorders, Neurologic
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov